Total Payments
$8,144
2024 Payments
$798.74
Companies
24
Transactions
143
Medicare Patients
1,234
Medicare Billing
$158,726
Payment Breakdown by Category
Consulting$3,848 (47.2%)
Food & Beverage$3,208 (39.4%)
Travel$1,070 (13.1%)
Education$17.61 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,848 | 1 | 47.2% |
| Food and Beverage | $3,208 | 136 | 39.4% |
| Travel and Lodging | $1,070 | 4 | 13.1% |
| Education | $17.61 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $4,660 | 26 | $0 (2024) |
| Medtronic MiniMed, Inc. | $826.49 | 5 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $501.59 | 20 | $0 (2024) |
| Medtronic, Inc. | $372.17 | 16 | $0 (2023) |
| Lilly USA, LLC | $347.68 | 15 | $0 (2024) |
| Amarin Pharma Inc. | $345.16 | 7 | $0 (2022) |
| Abbott Laboratories | $117.52 | 7 | $0 (2022) |
| CeQur Corporation | $112.80 | 2 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $105.58 | 4 | $0 (2024) |
| Amneal Pharmaceuticals LLC | $103.06 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $798.74 | 32 | Boehringer Ingelheim Pharmaceuticals, Inc. ($183.44) |
| 2023 | $267.21 | 12 | Medtronic, Inc. ($126.15) |
| 2022 | $1,024 | 54 | Novo Nordisk Inc ($198.79) |
| 2021 | $472.35 | 21 | Boehringer Ingelheim Pharmaceuticals, Inc. ($106.33) |
| 2020 | $40.93 | 3 | Novo Nordisk Inc ($22.50) |
| 2019 | $4,646 | 12 | Novo Nordisk Inc ($4,334) |
| 2018 | $894.53 | 9 | Medtronic MiniMed, Inc. ($826.49) |
All Payment Transactions
143 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: Cardio-renal | ||||||
| 12/17/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Obesity | ||||||
| 11/26/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $30.31 | General |
| Category: Cardio-renal | ||||||
| 11/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.14 | General |
| Category: DIABETES | ||||||
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: DIABETES | ||||||
| 11/01/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $15.76 | General |
| 10/29/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Cardio-renal | ||||||
| 10/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: DIABETES | ||||||
| 09/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Diabetes | ||||||
| 09/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: DIABETES | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $22.90 | General |
| 08/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Cardio-renal | ||||||
| 08/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Diabetes | ||||||
| 08/19/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Diabetes | ||||||
| 08/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: DIABETES | ||||||
| 08/07/2024 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $75.87 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 07/31/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/15/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Endocrinology | ||||||
| 06/18/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 359 | 421 | $124,318 | $33,318 |
| 2022 | 6 | 299 | 486 | $93,517 | $42,879 |
| 2021 | 6 | 320 | 548 | $106,992 | $51,649 |
| 2020 | 6 | 256 | 415 | $79,151 | $30,879 |
Total Patients
1,234
Total Services
1,870
Medicare Billing
$158,726
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 146 | 195 | $58,204 | $17,768 | 30.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 66 | $12,846 | $4,681 | 36.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $28,119 | $4,611 | 16.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 40 | 40 | $19,873 | $4,159 | 20.9% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 16 | 16 | $3,696 | $1,486 | 40.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 66 | 73 | $1,580 | $613.20 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 132 | 288 | $55,296 | $26,924 | 48.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 88 | 115 | $14,605 | $7,667 | 52.5% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 34 | 36 | $8,316 | $3,350 | 40.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $5,100 | $2,470 | 48.4% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2022 | 14 | 15 | $4,380 | $1,769 | 40.4% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2022 | 14 | 15 | $5,820 | $699.04 | 12.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 143 | 340 | $65,280 | $33,528 | 51.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 82 | 111 | $14,097 | $8,043 | 57.1% |
| 76536 | Ultrasound of head and neck | Office | 2021 | 41 | 41 | $9,471 | $3,998 | 42.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 20 | 20 | $6,000 | $2,954 | 49.2% |
| 10005 | Fine needle aspiration of first lesion using ultrasound guidance | Office | 2021 | 18 | 19 | $5,548 | $2,275 | 41.0% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Office | 2021 | 16 | 17 | $6,596 | $851.19 | 12.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 139 | 274 | $52,608 | $21,524 | 40.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 55 | 66 | $8,382 | $3,584 | 42.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 12 | 12 | $4,512 | $1,929 | 42.8% |
| 76536 | Ultrasound of head and neck | Office | 2020 | 20 | 20 | $4,620 | $1,688 | 36.5% |
| 10005 | Fine needle aspiration of first lesion using ultrasound guidance | Office | 2020 | 11 | 12 | $3,504 | $1,265 | 36.1% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 19 | 31 | $5,525 | $888.48 | 16.1% |
About Dr. Robert Aden, MD
Dr. Robert Aden, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457312829.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Aden, MD has received a total of $8,144 in payments from pharmaceutical and medical device companies, with $798.74 received in 2024. These payments were reported across 143 transactions from 24 companies. The most common payment nature is "Consulting Fee" ($3,848).
As a Medicare-enrolled provider, Aden has provided services to 1,234 Medicare beneficiaries, totaling 1,870 services with total Medicare billing of $158,726. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Endocrinology, Diabetes & Metabolism
- Location Brooklyn, NY
- Active Since 03/28/2006
- Last Updated 03/21/2024
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1457312829
Products in Payments
- Victoza (Drug) $4,278
- Minimed 670G System (Device) $826.49
- Vascepa (Drug) $345.16
- JARDIANCE (Drug) $299.00
- TRADJENTA (Drug) $245.67
- MINIMED 770G (Device) $150.87
- BAQSIMI (Drug) $148.09
- Ozempic (Drug) $147.16
- Rybelsus (Drug) $141.63
- CeQur Simplicity (Device) $112.80
- Kerendia (Drug) $105.58
- UNITHROID (Drug) $103.06
- FREESTYLE LIBRE 2 (Device) $96.62
- InPen (Device) $96.14
- MINIMED 780G (Device) $76.99
- TEPEZZA (Biological) $66.55
- JANUVIA (Drug) $57.23
- MOUNJARO (Drug) $55.22
- INPEN SMART INSULIN DELIVERY SYSTEM (Device) $48.17
- GVOKE PFS (Drug) $42.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Brooklyn
Dr. Matin Sharafatkhah, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $437,076
Endocrinology, Diabetes & Metabolism $437,076
Dr. Matvey Brokhin, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $373,852
Endocrinology, Diabetes & Metabolism $373,852
Dr. Robert Silver, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $354,536
Endocrinology, Diabetes & Metabolism $354,536
Alexander Perkelvald, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $343,784
Endocrinology, Diabetes & Metabolism $343,784
Dr. Iraklii Buziashvili, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $122,903
Endocrinology, Diabetes & Metabolism $122,903
Dr. Saka Kazeem, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $23,364
Endocrinology, Diabetes & Metabolism $23,364